Abstract
We described here the synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as potential mGluR5 antagonists. We found that a series of thiazole derivatives 6 showed better inhibitory activity against mGluR5. Compounds 6bc and 6bj have been identified as potent antagonists (IC50 = 274 and 159 nM) showing excellent in vitro stability profile. Molecular docking study using the crystal structure of mGluR5 revealed that our compounds 6bc and 6bj fit the allosteric binding site of mavoglurant well.
Original language | English |
---|---|
Pages (from-to) | 140-144 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 26 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2016 Jan 1 |
Bibliographical note
Funding Information:This research was supported by the Korea Institute of Science and Technology (KIST, 2E25580 , 2E25473 , 2E25240 , 2V03970 ) and by a Grant of the National Research Foundation of Korea ( NRF-2013R1A1A2005550 and NRF-2015M3A9A8030034 ) funded by the Ministry of Science, ICT and Future Planning .
Publisher Copyright:
© 2015 Elsevier Ltd. All rights reserved.
Keywords
- Antagonist
- Metabotropic glutamate receptor
- Molecular docking
- Picolinamides
- Thiazole-2-carboxamides
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry